Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

EU flag

EC approves UCB’s Zilbrysq as generalised myasthenia gravis add-on therapy

The autoimmune disease has a global prevalence of 100 to 350 cases per every one million people

- PMLiVE

Global donors pledge over $777m to fight neglected tropical diseases at COP28 summit

The $500m Reaching the Last Mile Fund will reach an additional 32 countries

- PMLiVE

Roche to acquire Carmot Therapeutics in deal worth up to $3.1bn

The company will gain access to a portfolio of incretin-based therapies for diabetes and obesity

- PMLiVE

Eli Lilly’s Jaypirca granted FDA accelerated approval for non-Hodgkin lymphomas

Approximately 18,740 new cases of CLL have been diagnosed in the US this year

- PMLiVE

Cancer Research UK and Guardant collaborate to advance cancer detection and treatment

The partnership aims to accelerate the development of cancer drugs and diagnostics

- PMLiVE

UK-India research project trialling easy-to-use UTI test to support fight against AMR

AMR has been declared by WHO as one of the top ten threats to global public health

- PMLiVE

Give the gift of positive change

By Claire Long

- PMLiVE

Apple Vision Pro: challenges and opportunities for pharma

By Andrew Lamb

- PMLiVE

The Power of the Partnership: How Patient-Centricity Improves Care

How can the patient’s voice improve care?This was the question Medscape Oncology Clinical Strategist Victoria Harvey-Jones, PhD and Lesley Fallowfield DBE, BSC, DPHIL, FMEDSCI, Professor of Pyscho-Oncology, Sussex Health Outcomes...

Medscape Education

New Playbook Alert: Virtual Patient Engagement

Authentic patient engagement and insight-gathering are becoming must-haves in Pharma. However, multiple obstacles remain before patient-centricity becomes more than a buzzword. In our latest playbook, we take a deep dive...

Impetus Digital

- PMLiVE

UK Biobank reveals new data from world’s largest genetic project

The data will accelerate the development of potentially lifesaving treatments and cures

- PMLiVE

AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition

The agreement grants the company access to FDA-approved ovarian cancer drug Elahere

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links